Gastroesophageal Reflux Disease Devices Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Description
Market Overview
The Gastroesophageal Reflux Disease (GERD) Devices Market is projected to increase from USD 1,187.3 million in 2024 to an estimated USD 1,575.57 million by 2032, representing a compound annual growth rate (CAGR) of 3.6% from 2024 to 2032.
Market expansion is primarily driven by the rising prevalence of GERD, attributed to lifestyle shifts, poor dietary patterns, and the growing incidence of obesity. The increasing geriatric population—more prone to chronic acid reflux—further amplifies demand. In parallel, the shift toward minimally invasive treatment methods, including magnetic sphincter augmentation and endoscopic procedures, is displacing traditional surgical approaches. Technological advancements, such as wireless pH monitoring and impedance-pH probes, are enhancing the precision and comfort of diagnostics, facilitating early intervention and improved treatment efficacy. In addition, growing public awareness of GERD complications, favorable policy support, and the introduction of cost-effective therapeutic options are collectively contributing to the market’s sustained growth trajectory.
Market Drivers
Innovation in GERD Diagnostics and Treatment Solutions
Technological advancements are significantly accelerating the adoption of GERD management devices. Innovations in diagnostics—such as wireless pH monitoring and impedance-pH systems—offer minimally invasive, accurate, and patient-centric approaches for assessing disease severity and guiding personalized treatment plans. For instance, Medtronic’s Bravo™ system enables 48-hour wireless pH monitoring, enhancing diagnostic comfort and accuracy. On the therapeutic front, non-surgical alternatives like magnetic sphincter augmentation and endoscopic devices are increasingly favored due to faster recovery and sustained symptom relief. These technologies are improving clinical outcomes and decreasing reliance on long-term medication, thus appealing to both patients and healthcare providers.
Market Challenges Analysis
Cost Barriers Limiting Access to Advanced GERD Solutions
A major obstacle to market growth is the high cost of advanced GERD diagnostic and treatment technologies. Devices such as wireless pH monitors, magnetic sphincter systems, and endoscopic therapies involve significant development and deployment expenses. These elevated costs limit affordability, particularly in emerging markets and among underinsured populations. As a result, access to effective GERD interventions remains uneven, curbing broader market penetration and creating disparities in treatment availability.
Market Segmentation
By Product:
Diagnostic Devices:
Manometry Systems
PH Monitoring Systems
Esophagoscopes and Gastroscopes
Treatment Devices:
Ultrasonic Surgical Endostaplers
Fundoplication Devices
Sphincter Augmentation Devices
Radiofrequency Ablation Devices
By Procedure:
Diagnostic Procedures
Fundoplication Procedures
Radiofrequency Thermal Ablation
Magnetic Sphincter Augmentation
By End User:
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
By Region:
North America:
U.S.
Canada
Mexico
Europe:
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific:
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America:
Brazil
Argentina
Rest of Latin America
Middle East & Africa:
GCC Countries
South Africa
Rest of Middle East and Africa
Key Player Analysis
Diversatek Inc.
EndoGastric Solutions
Fujifilm Holdings Corporation
KARL STORZ SE & Co. KG
Medigus Ltd.
Medtronic Plc
Olympus Corporation
Pentax Medical
The Gastroesophageal Reflux Disease (GERD) Devices Market is projected to increase from USD 1,187.3 million in 2024 to an estimated USD 1,575.57 million by 2032, representing a compound annual growth rate (CAGR) of 3.6% from 2024 to 2032.
Market expansion is primarily driven by the rising prevalence of GERD, attributed to lifestyle shifts, poor dietary patterns, and the growing incidence of obesity. The increasing geriatric population—more prone to chronic acid reflux—further amplifies demand. In parallel, the shift toward minimally invasive treatment methods, including magnetic sphincter augmentation and endoscopic procedures, is displacing traditional surgical approaches. Technological advancements, such as wireless pH monitoring and impedance-pH probes, are enhancing the precision and comfort of diagnostics, facilitating early intervention and improved treatment efficacy. In addition, growing public awareness of GERD complications, favorable policy support, and the introduction of cost-effective therapeutic options are collectively contributing to the market’s sustained growth trajectory.
Market Drivers
Innovation in GERD Diagnostics and Treatment Solutions
Technological advancements are significantly accelerating the adoption of GERD management devices. Innovations in diagnostics—such as wireless pH monitoring and impedance-pH systems—offer minimally invasive, accurate, and patient-centric approaches for assessing disease severity and guiding personalized treatment plans. For instance, Medtronic’s Bravo™ system enables 48-hour wireless pH monitoring, enhancing diagnostic comfort and accuracy. On the therapeutic front, non-surgical alternatives like magnetic sphincter augmentation and endoscopic devices are increasingly favored due to faster recovery and sustained symptom relief. These technologies are improving clinical outcomes and decreasing reliance on long-term medication, thus appealing to both patients and healthcare providers.
Market Challenges Analysis
Cost Barriers Limiting Access to Advanced GERD Solutions
A major obstacle to market growth is the high cost of advanced GERD diagnostic and treatment technologies. Devices such as wireless pH monitors, magnetic sphincter systems, and endoscopic therapies involve significant development and deployment expenses. These elevated costs limit affordability, particularly in emerging markets and among underinsured populations. As a result, access to effective GERD interventions remains uneven, curbing broader market penetration and creating disparities in treatment availability.
Market Segmentation
By Product:
Diagnostic Devices:
Manometry Systems
PH Monitoring Systems
Esophagoscopes and Gastroscopes
Treatment Devices:
Ultrasonic Surgical Endostaplers
Fundoplication Devices
Sphincter Augmentation Devices
Radiofrequency Ablation Devices
By Procedure:
Diagnostic Procedures
Fundoplication Procedures
Radiofrequency Thermal Ablation
Magnetic Sphincter Augmentation
By End User:
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
By Region:
North America:
U.S.
Canada
Mexico
Europe:
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific:
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America:
Brazil
Argentina
Rest of Latin America
Middle East & Africa:
GCC Countries
South Africa
Rest of Middle East and Africa
Key Player Analysis
Diversatek Inc.
EndoGastric Solutions
Fujifilm Holdings Corporation
KARL STORZ SE & Co. KG
Medigus Ltd.
Medtronic Plc
Olympus Corporation
Pentax Medical
Table of Contents
199 Pages
- CHAPTER NO. 1 : INTRODUCTION
- 1.1.1. Report Description
- Purpose of the Report
- USP & Key Offerings
- 1.1.2. Key Benefits for Stakeholders
- 1.1.3. Target Audience
- 1.1.4. Report Scope
- CHAPTER NO. 2 : EXECUTIVE SUMMARY
- 2.1. Gastroesophageal Reflux Disease Devices Market Snapshot
- 2.1.1. Gastroesophageal Reflux Disease Devices Market, 2018 - 2032 (USD Million)
- CHAPTER NO. 3 : Gastroesophageal Reflux Disease Devices Market – INDUSTRY ANALYSIS
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Market Opportunities
- 3.5. Porter’s Five Forces Analysis
- CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE
- 4.1. Company Market Share Analysis – 2023
- 4.2. Gastroesophageal Reflux Disease Devices Market Company Revenue Market Share, 2023
- 4.3. Company Assessment Metrics, 2023
- 4.4. Start-ups /SMEs Assessment Metrics, 2023
- 4.5. Strategic Developments
- 4.6. Key Players Product Matrix
- CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS
- CHAPTER NO. 6 : Gastroesophageal Reflux Disease Devices Market – BY By Product: ANALYSIS
- CHAPTER NO. 7 : Gastroesophageal Reflux Disease Devices Market – BY By Procedure: ANALYSIS
- CHAPTER NO. 8 : Gastroesophageal Reflux Disease Devices Market – BY By End User: ANALYSIS
- CHAPTER NO. 9 : Gastroesophageal Reflux Disease Devices Market – BY By Region: ANALYSIS
- CHAPTER NO. 10 : COMPANY PROFILES
- 10.1. Diversatek Inc.
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio
- 10.1.3. Swot Analysis
- 10.1.4. Business Strategy
- 10.1.5. Financial Overview
- 10.2. EndoGastric Solutions
- 10.3. Fujifilm Holdings Corporation
- 10.4. KARL STORZ SE and Co KG.
- 10.5. Medigus Ltd.
- 10.6. Medtronic Plc
- 10.7. Olympus Corporation
- 10.8. Pentax Medical
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
